Codex Funding & Investors
San Diego, CA
Codex DNA is a pioneer in synthetic Biology. We’ve commercialized the world's first fully automated biologics printer. It harnesses the power and precision of the Gibson Assembly® method to synthesize genes in a single overnight operation on the benchtop. Our vision is to bridge the gap between the digital and biological worlds by developing revolutionary synthetic genomics platforms that accelerate advances in drug discovery, precision medicine, DNA data storage, and industrial design.
codexdna.comTotal Amount Raised: $99,200,000
Codex Funding Rounds
Post Ipo Equity
$74,200,000
Post Ipo Equity Investors
Novalis LifeSciencesBroadOak Capital PartnersM-185 CorporationNorthpond VenturesSeries A
$25,000,000
Series A Investors
Oxford FinanceBroadOak Capital PartnersNorthpond VenturesIPO
Unknown
Funding info provided by Diffbot.